Brainstorm Cell Therapeutics | BCLI - Market Capitalization


Brainstorm Cell Therapeutics reported $46.5M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 39M 17M Sep/2026
Biogen USD 31.9B 5B Jun/2026
Brainstorm Cell Therapeutics USD 11M 3M Mar/2026
Cipla INR 1.18T 194.93B Jun/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.29M 475.62M Mar/2026
CSL USD 55.89B 20.42B Dec/2025
Cytokinetics USD 11.55B 3.36B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Mesoblast USD 1.75B 577.14M Jun/2026